Advertisement

Index by author

September 01, 2015; Volume 354,Issue 3

  1. Abernethy, Darrell R.

    1. Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells
      Vaishali L. Chudasama, Meric A. Ovacik, Darrell R. Abernethy and Donald E. Mager
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 448-458; DOI: https://doi.org/10.1124/jpet.115.224766

  2. Acri, Jane B.

    1. Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs
      Nathan M. Appel, Shou-Hua Li, Tyson H. Holmes and Jane B. Acri
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 484-492; DOI: https://doi.org/10.1124/jpet.115.224121

  3. Aguilar, Zuleima

    1. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
      Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Diane Nepomuceno, Steven Sutton, Leah Aluisio, Ian Fraser, Brian Lord, James Shoblock, Natalie Welty, Sandra R. Chaplan, Zuleima Aguilar, Robin Halter, Anthony Ndifor, Tatiana Koudriakova, Michele Rizzolio, Michael Letavic, Nicholas I. Carruthers, Timothy Lovenberg and Christine Dugovic
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 471-482; DOI: https://doi.org/10.1124/jpet.115.225466

  4. Alber, Hannes

    1. CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine
      Martin Klieber, Herbert Oberacher, Silvia Hofstaetter, Beate Beer, Martin Neururer, Anton Amann, Hannes Alber and Anil Modak
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 426-430; DOI: https://doi.org/10.1124/jpet.115.225680

  5. Aldegheri, Laura

    1. A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons
      Marcelo D. Rosato-Siri, Erika Zambello, Chiara Mutinelli, Nicoletta Garbati, Roberto Benedetti, Laura Aldegheri, Francesca Graziani, Caterina Virginio, Giuseppe Alvaro and Charles H. Large
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 251-260; DOI: https://doi.org/10.1124/jpet.115.225748

  6. Alt, Andrew

    1. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity
      Martin A. Lewis, Lisa Hunihan, John Watson, Robert G. Gentles, Shuanghua Hu, Yazhong Huang, Joanne Bronson, John E. Macor, Brett R. Beno, Meredith Ferrante, Adam Hendricson, Ronald J. Knox, Thaddeus F. Molski, Yan Kong, Mary Ellen Cvijic, Kristin L. Rockwell, Michael R. Weed, Angela M. Cacace, Ryan S. Westphal, Andrew Alt and Jeffrey M. Brown
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 340-349; DOI: https://doi.org/10.1124/jpet.115.224071

  7. Aluisio, Leah

    1. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
      Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Diane Nepomuceno, Steven Sutton, Leah Aluisio, Ian Fraser, Brian Lord, James Shoblock, Natalie Welty, Sandra R. Chaplan, Zuleima Aguilar, Robin Halter, Anthony Ndifor, Tatiana Koudriakova, Michele Rizzolio, Michael Letavic, Nicholas I. Carruthers, Timothy Lovenberg and Christine Dugovic
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 471-482; DOI: https://doi.org/10.1124/jpet.115.225466

  8. Alvaro, Giuseppe

    1. A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons
      Marcelo D. Rosato-Siri, Erika Zambello, Chiara Mutinelli, Nicoletta Garbati, Roberto Benedetti, Laura Aldegheri, Francesca Graziani, Caterina Virginio, Giuseppe Alvaro and Charles H. Large
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 251-260; DOI: https://doi.org/10.1124/jpet.115.225748

  9. Amann, Anton

    1. CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine
      Martin Klieber, Herbert Oberacher, Silvia Hofstaetter, Beate Beer, Martin Neururer, Anton Amann, Hannes Alber and Anil Modak
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 426-430; DOI: https://doi.org/10.1124/jpet.115.225680

  10. Ambudkar, Suresh V.

    1. The Inhibitor Ko143 Is Not Specific for ABCG2
      Lora D. Weidner, Sami S. Zoghbi, Shuiyu Lu, Suneet Shukla, Suresh V. Ambudkar, Victor W. Pike, Jan Mulder, Michael M. Gottesman, Robert B. Innis and Matthew D. Hall
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 384-393; DOI: https://doi.org/10.1124/jpet.115.225482
« Previous (Pages : 1 2 3 4 5 6 ... 22) Next »
Back to top

In this issue

Advertisement